Analysts Set Veeva Systems Inc. (NYSE:VEEV) PT at $276.52

Veeva Systems Inc. (NYSE:VEEV) has earned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $276.5217.

VEEV has been the subject of a number of research reports. Wall Street Zen downgraded Veeva Systems from a “buy” rating to a “hold” rating in a report on Sunday, March 22nd. Piper Sandler decreased their price objective on Veeva Systems from $355.00 to $285.00 and set an “overweight” rating for the company in a report on Thursday, March 5th. Needham & Company LLC reduced their price target on Veeva Systems from $355.00 to $270.00 and set a “buy” rating for the company in a report on Thursday, March 5th. Barclays reduced their price target on Veeva Systems from $305.00 to $250.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Finally, Citigroup downgraded Veeva Systems from a “buy” rating to a “neutral” rating and reduced their price target for the company from $291.00 to $176.00 in a report on Friday, April 10th.

Key Stories Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced that Kindeva, a global CDMO, is adopting Veeva Quality Cloud to unify sites on a single platform, which supports Veeva’s growth narrative and could boost future recurring software revenue. Why Veeva Systems (VEEV) Stock Is Up Today
• Positive Sentiment: Coverage highlighting Veeva versus IQVIA points to strong industry tailwinds from life sciences digitization, with Veeva viewed as benefiting from AI adoption and a premium business model. Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?
• Neutral Sentiment: Several articles previewed Wall Street’s key metric estimates for Veeva’s upcoming quarter, suggesting investors are watching whether the company can meet growth expectations, but these pieces did not include a new earnings surprise or guidance update. Unveiling Veeva (VEEV) Q1 Outlook: Wall Street Estimates for Key Metrics
• Neutral Sentiment: Veeva was also highlighted as a trending stock and covered in analyst-style writeups noting a “Moderate Buy” consensus, which supports attention on the name but does not by itself change fundamentals. Veeva Systems Inc. (NYSE:VEEV) Given Average Recommendation of “Moderate Buy” by Analysts

Insider Buying and Selling at Veeva Systems

In other news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the transaction, the director directly owned 3,253 shares in the company, valued at $506,296.92. This trade represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Veeva Systems

Institutional investors and hedge funds have recently modified their holdings of the stock. GPS Wealth Strategies Group LLC increased its holdings in shares of Veeva Systems by 196.4% during the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock valued at $25,000 after acquiring an additional 55 shares in the last quarter. SHP Wealth Management bought a new position in shares of Veeva Systems during the fourth quarter valued at $26,000. Board of the Pension Protection Fund bought a new position in shares of Veeva Systems during the fourth quarter valued at $27,000. Raiffeisen Bank International AG bought a new position in shares of Veeva Systems during the third quarter valued at $28,000. Finally, Newbridge Financial Services Group Inc. boosted its position in shares of Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 100 shares during the last quarter. 88.20% of the stock is currently owned by institutional investors.

Veeva Systems Trading Up 5.8%

VEEV opened at $173.97 on Thursday. The stock has a fifty day simple moving average of $166.38 and a two-hundred day simple moving average of $199.77. The company has a market cap of $28.42 billion, a price-to-earnings ratio of 32.16, a price-to-earnings-growth ratio of 0.77 and a beta of 0.92. Veeva Systems has a 12-month low of $148.05 and a 12-month high of $310.50.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $835.95 million during the quarter, compared to the consensus estimate of $810.95 million. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The firm’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, analysts predict that Veeva Systems will post 6.45 EPS for the current year.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.